Even in a country like Australia, with a high standard of living and a socialised health system, the battle to eliminate hepatitis can be challenging. So what is it like in a country like India, where poverty, population pressures and lack of health funding and education make every medical challenge so much harder?
Dr Sunil Solomon is Associate Professor of Medicine at the prestigious Johns Hopkins University School of Medicine. He spoke at the Australasian Viral Hepatitis Conference in Adelaide about his work on eliminating HCV among people in India who inject drugs.
Continue reading “Treating Hepatitis C Under Nearly Impossible Conditions”
Taking every dose of your direct-acting antiviral gives you the best chance of a cure. Because many of these drugs are new, it’s not yet clear how missed doses may affect the success of your treatment, so it’s better to be safe than sorry and try not to miss any dose.
Remembering every dose can be difficult even when motivation is high and the treatment course short, as is the case for most people on the new hepatitis C medicines. The information that came with your drug should advise you on what to do if you do miss a dose and whether you should take it later or skip it.
Continue reading “Curing Your Hep C – Tips for remembering to take every dose”
The development of direct-acting antiviral (DAA) treatments has revolutionised the treatment of hepatitis C in Australia. DAAs are effective and, when patients follow the medication regime, can cure more than 90% of those who take the treatment. But at the moment there are limited resources to inform and guide health professionals as they try to provide adherence support to those undergoing DAA treatment.
Medication adherence refers to the way an individual takes a medication, including the use of the correct medication, the correct dose and time, duration and timely refilling of repeat prescriptions.
Continue reading “Helping People Adhere to Treatment Helps Treatment Succeed”